Microbiology

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


2372 publications

In press | 2024 | 2023 | 2022 | ...
In press
 
Assessing ChatGPT's theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists.
De Vito A., Geremia N., Marino A., Bavaro D.F., Caruana G., Meschiari M., Colpani A., Mazzitelli M., Scaglione V., Venanzi Rullo E. et al. Infection. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_019BD30F4EC5]
 
Oropouche virus: A re-emerging arbovirus of clinical significance.
Desai A.N., Otter A., Koopmans M., Granata G., Grobusch M.P., Tunali V., Astorri R., Jokelainen P., Greub G., Ergönül Ö. et al. International journal of infectious diseases. Peer-reviewed.
[DOI][Pmid][serval:BIB_872FFE770078]
 
KSA-1, a naturally occurring Ambler class A extended spectrum β-lactamase from the enterobacterial species Kosakonia sacchari.
Fournier C., Nordmann P., de la Rosa J.O., Kusaksizoglu A., Poirel L. Journal of global antimicrobial resistance. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B96A56C58389]
 
Duration of antimicrobial treatment for uncomplicated streptococcal bacteraemia: Another example of shorter is better.
Fourré N., Zimmermann V., Senn L., Aruanno M., Guery B., Papadimitriou-Olivgeris M. The Journal of infection. Peer-reviewed.
[DOI][Pmid][serval:BIB_52973F9DBA1A]
 
Conference report: The first Bacterial Genome Sequencing Pan-European Network Conference.
Germuskova Z., Sosa E., Lagos A.C., Aamot H.V., Beale M.A., Bertelli C., Björkmann J., Couto N., Feige L., Greub G. et al. Microbes and infection. Peer-reviewed.
[DOI][Pmid][serval:BIB_01041FBBDEC4]
 
A potential role for chlamydial infection in rheumatoid arthritis development.
Lamacchia C., Aymon R., Hattel B.C., Aeby S., Kebbi-Beghdadi C C., Gilbert B., Studer O., Norris J.M., Nolers M.V., Demoruelle M.K. et al. Rheumatology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_42DABD0BE29B]
 
Exploration of novel mechanisms of azole resistance in Candida auris.
Li J., Brandalise D., Coste A.T., Sanglard D., Lamoth F. Antimicrobial agents and chemotherapy. Peer-reviewed.
[DOI][Pmid][serval:BIB_833F84ADFDA1]
2024
 
Ume6-dependent pathways of morphogenesis and biofilm formation in Candida auris.
Louvet M., Li J., Brandalise D., Bachmann D., Sala de Oyanguren F., Labes D., Jacquier N., Genoud C., Mucciolo A., Coste A.T. et al., 2024/11/05. Microbiology spectrum, 12 (11) pp. e0153124. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21541699EAF6]
Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families.
Martina M.G., Carlen V., Van der Reysen S., Bianchi E., Cabella N., Crespan E., Radi M., Cagno V., 2024/11. Antiviral research, 231 p. 106003. Peer-reviewed.
[DOI][Pmid][serval:BIB_4C98CFE02CBF]
Nanomotion technology: an innovative method to study cell metabolism in Escherichia coli, as a potential indicator for tolerance.
Aubry C., Kebbi-Beghdadi C., Luraschi-Eggemann A., Cathomen G., Cichocka D., Sturm A., Greub G., The Eradiamr Consortium, 2024/11. Journal of medical microbiology, 73 (11). Peer-reviewed.
[DOI][Pmid][serval:BIB_ED9633354811]
Syphilis in pregnant women and congenital syphilis from 2012 to 2021 in Switzerland: a multicentre, retrospective study.
Alberto C., Wagner N., Fougère Y., Meyer Sauteur P.M., Scherler G., Aebbi-Popp K., Baumann M., Schöbi N., Catho G., Emonet S. et al., 2024/11/01. Swiss medical weekly, 154 p. 3678. Peer-reviewed.
[DOI][Pmid][serval:BIB_20622B162454]
 
European Study of Cerebral Aspergillosis treated with Isavuconazole (ESCAI): A study by the ESCMID Fungal Infection Study Group.
Serris A., Rautemaa-Richardson R., Laranjinha J.D., Candoni A., Garcia-Vidal C., Alastruey-Izquierdo A., Hammarström H., Seidel D., Styczynski J., Sabino R. et al., 2024/10/15. Clinical infectious diseases, 79 (4) pp. 936-943. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_835D7D75C12A]
 
UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract.
Stritt K., Roth B., Masnada A., Hammann F., Jacot D., Domingos-Pereira S., Crettenand F., Bohner P., Sommer I., Bréat E. et al., 2024/10/15. Trials, 25 (1) p. 682. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AE2B4EB30E66]
 
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.
Damas J., Munting A., Fellay J., Haerry D., Marzolini C., Tarr P.E., Steffen A., Braun D.L., Stoeckle M., Bernasconi E. et al., 2024/10/15. Clinical infectious diseases, 79 (4) pp. 990-998. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A22E1C92231B]
Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon.
Alabi A., Kokou K., Mahmoudou S., Kavishna R., Nakka S.S., Rothenberger S., Musangomunei F.P., Olubiyi B.F., Bie-Ondo J.C., Kabwende A.L. et al., 2024/10. The Journal of infection, 89 (4) p. 106237. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_14DDC9627FCC]
 
Role of source control in critically ill candidemic patients: a multicenter retrospective study.
Marangos M., Ioannou P., Senn L., Spiliopoulou A., Tzalis S., Kolonitsiou F., Valta M., Kokkini S., Pagani J.L., Stafylaki D. et al., 2024/10. Infection, 52 (5) pp. 1733-1743. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E12FF5C85FA]
 
Detection of volatile organic compounds as new paradigm to accelerate antimicrobial susceptibility testing: performance evaluation of VITEK® REVEAL™.
Bianco G., Boattini M., Comini S., Bondi A., Curtoni A., Piccinini G., Musso T., Broccolo F., Cavallo R., Nordmann P. et al., 2024/09/03. The Journal of antimicrobial chemotherapy, 79 (9) pp. 2237-2245. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9DA12010D916]
 
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
Fernbach S., Mair N.K., Abela I.A., Groen K., Kuratli R., Lork M., Thorball C.W., Bernasconi E., Filippidis P., Leuzinger K. et al., 2024/09/02. The Journal of experimental medicine, 221 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_091D90E14C02]
 
Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag).
Buhl MEJ, Sunnerhagen T., Join-Lambert O., Morris T., Jeverica S., Assous M.V., Toprak N.U., Alcalá-Hernandez L., Lienhard R., Veloo ACM et al., 2024/09. International journal of antimicrobial agents, 64 (3) p. 107241. Peer-reviewed.
[DOI][Pmid][serval:BIB_CCC6ED280465]
 
Development of novel broad-range pan-genus PCR assays for the detection of Tropheryma species.
Tagini F., Belkoniene M., Jaton K., Opota O., Greub G., 2024/09. Journal of medical microbiology, 73 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6ABCC5D8FB1]
 
Implications of the 2023-2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health.
Desai A.N., Koopmans M., Otter A., Grobusch M.P., Jokelainen P., Atkinson B., Cunha F., Valdoleiros S.R., Preda V.G., Fusco F.M. et al., 2024/09. Clinical microbiology and infection, 30 (9) pp. 1092-1094. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BA85E7D1671]
 
The world health organization pandemic agreement draft: considerations by the European Society of Clinical Microbiology and Infectious Diseases Emerging Infections Task Force.
Granata G., Astorri R., Broens E.M., Callaby H., Cunha F., Di Caro A., Fusco F.M., Greub G., Grobusch M.P., Koopmans M. et al., 2024/09. Clinical microbiology and infection, 30 (9) pp. 1095-1099. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_933E55DD88AA]
Association of pathogenic determinants of Fusobacterium necrophorum with bacteremia, and Lemierre's syndrome.
Carrara A., Bertelli C., Gardiol C., Marquis B., Andrey D.O., Schrenzel J., Pillonel T., Greub G., 2024/08/27. Scientific reports, 14 (1) p. 19804. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A29B2514B933]
 
Evaluation of the HANDOC Score and the 2023 International Society of Cardiovascular Infectious Diseases and European Society of Cardiology Duke Clinical Criteria for the Diagnosis of Infective Endocarditis Among Patients With Streptococcal Bacteremia.
Fourré N., Zimmermann V., Senn L., Monney P., Tzimas G., Caruana G., Tozzi P., Kirsch M., Guery B., Papadimitriou-Olivgeris M., 2024/08/16. Clinical infectious diseases, 79 (2) pp. 434-442. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D5830974376]
 
Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening.
Mathez G., Brancale A., Cagno V., 2024/08/12. Journal of chemical information and modeling, 64 (15) pp. 6190-6196. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C7478C5D69A]
The AP-1 adaptor complex is essential for intracellular trafficking of the ORF2 capsid protein and assembly of Hepatitis E virus.
Ferrié M., Alexandre V., Montpellier C., Bouquet P., Tubiana T., Mézière L., Ankavay M., Bentaleb C., Dubuisson J., Bressanelli S. et al., 2024/08/09. Cellular and molecular life sciences, 81 (1) p. 335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_39808203A410]
 
A reporter virus particle seroneutralization assay for tick-borne encephalitis virus overcomes ELISA limitations.
Ackermann-Gäumann R., Dentand A., Lienhard R., Saeed M., Speiser D.E., MacDonald M.R., Coste A.T., Cagno V., 2024/08. Journal of medical virology, 96 (8) pp. e29843. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60C8B876F1D2]
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual.
Yeoh K., Lass-Flörl C., Lamoth F., Slavin M.A., Williams E., Neofytos D., 2024/08. Transplant infectious disease, 26 (4) pp. e14273. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6497609B679D]
MultiRapid ATB NP test for detecting concomitant susceptibility and resistance of last-resort novel antibiotics available to treat multidrug-resistant Enterobacterales infections.
Raro OHF, Bouvier M., Kerbol A., Poirel L., Nordmann P., 2024/08. International journal of antimicrobial agents, 64 (2) p. 107206. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B98A5F3DA463]
 
zDB: bacterial comparative genomics made easy.
Marquis B., Pillonel T., Carrara A., Bertelli C., 2024/07/23. mSystems, 9 (7) pp. e0047324. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_98D21FF7E6AB]
 
A potential space-making role in cell wall biogenesis for SltB1and DacB revealed by a beta-lactamase induction phenotype in Pseudomonas aeruginosa.
Gyger J., Torrens G., Cava F., Bernhardt T.G., Fumeaux C., 2024/07/17. mBio, 15 (7) pp. e0141924. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_54562044E927]
Genomic evolution of ST228 SCCmec-I MRSA 10 years after a major nosocomial outbreak.
Mauffrey F., Bertelli C., Greub G., Senn L., Blanc D.S., 2024/07/16. Journal of clinical microbiology, 62 (7) pp. e0020324. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_729009233F3E]
 
Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
Cancela Costa A., Kritikos A., Glampedakis E., Da Silva Pereira Clara J., Schaller F., Mercier T., Strasser R., Balmpouzis Z., Koutsokera A., Manuel O. et al., 2024/07/01. The Journal of antimicrobial chemotherapy, 79 (7) pp. 1668-1672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94BC817AB3D7]
 
The Impact of Laboratory Automation on the Time to Urine Microbiological Results: A Five-Year Retrospective Study.
Kritikos A., Prod'hom G., Jacot D., Croxatto A., Greub G., 2024/06/29. Diagnostics, 14 (13). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74B2659891E7]
Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study.
Fourre N., Zimmermann V., Senn L., Aruanno M., Guery B., Papadimitriou-Olivgeris M., 2024/06/14. Clinical infectious diseases, 78 (6) pp. 1544-1550. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FBE241ACE9B2]
 
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.
Hoenigl M., Arastehfar A., Arendrup M.C., Brüggemann R., Carvalho A., Chiller T., Chen S., Egger M., Feys S., Gangneux J-P et al., 2024/06/13. Clinical microbiology reviews, 37 (2) pp. e0007423. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_820F4708FB65]
 
The genomic and phylogenetic analysis of Marseillevirus cajuinensis raises questions about the evolution of Marseilleviridae lineages and their taxonomical organization.
de Azevedo B.L., Queiroz V.F., de Aquino ILM, Machado T.B., de Assis F.L., Reis E., Araújo Júnior J.P., Ullmann L.S., Colson P., Greub G. et al., 2024/06/13. Journal of virology, 98 (6) pp. e0051324. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EBE6250F0570]
Correction to: Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
Andenmatten S., Opota O., Mazza-Stalder J., Nicod L., Greub G., Jaton K., 2024/06. European journal of clinical microbiology & infectious diseases, 43 (6) p. 1259. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4A965E41817]
 
Tularemia on the rise in Switzerland? A one health approach is needed!
Buettcher M., Egli A., Albini S., Altpeter E., Labutin A., Guidi V., Tonolla M., Lienhard R., Opota O., Schmid P. et al., 2024/06. Infection, 52 (3) pp. 1165-1169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_07E001134BB6]
 
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections.
Barbieri F., Carlen V., Martina M.G., Sannio F., Cancade S., Perini C., Restori M., Crespan E., Maga G., Docquier J.D. et al., 2024/05/22. RSC medicinal chemistry, 15 (5) pp. 1589-1600. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_23D504EAF025]
Benzene with Alkyl Chains Is a Universal Scaffold for Multivalent Virucidal Antivirals.
Zhu Y., Gasbarri M., Zebret S., Pawar S., Mathez G., Diderich J., Valencia-Camargo A.D., Russenberger D., Wang H., Silva PHJ et al., 2024/05/22. ACS central science, 10 (5) pp. 1012-1021. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D699DFB0BBF2]
Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase.
Bibert S., Quinodoz M., Perriot S., Krebs F.S., Jan M., Malta R.C., Collinet E., Canales M., Mathias A., Faignart N. et al., 2024/05/10. Nature communications, 15 (1) p. 3969. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63AF76DC891D]
Development and evaluation of an artificial intelligence for bacterial growth monitoring in clinical bacteriology.
Jacot D., Gizha S., Orny C., Fernandes M., Tricoli C., Marcelpoil R., Prod'hom G., Volle J-M, Greub G., Croxatto A., 2024/05/08. Journal of clinical microbiology, 62 (5) pp. e0165123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA319F0D5E34]
 
Screening of Small-Molecule Libraries Using SARS-CoV-2-Derived Sequences Identifies Novel Furin Inhibitors.
Jorkesh A., Rothenberger S., Baldassar L., Grybaite B., Kavaliauskas P., Mickevicius V., Dettin M., Vascon F., Cendron L., Pasquato A., 2024/05/07. International journal of molecular sciences, 25 (10). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F00CF02496F]
How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort.
Wegner F., Cabrera-Gil B., Tanguy A., Beckmann C., Beerenwinkel N., Bertelli C., Carrara M., Cerutti L., Chen C., Cordey S. et al., 2024/05/02. Microbiology spectrum, 12 (5) pp. e0362823. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6B5035C9655]
Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update.
Portillo V., Ragozzino S., Stavropoulou E., El-Khoury C., Bochud P.Y., Lamoth F., Khanna N., Neofytos D., 2024/05. Open forum infectious diseases, 11 (5) pp. ofae201. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB82840AB3F4]
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).
Couchepin J., Reinhold I., Kronig I., Guidi M., Buclin T., Schreiber P.W., Neofytos D., Lamoth F., Fungal Infection Network of Switzerland (FUNGINOS), 2024/05. Open forum infectious diseases, 11 (5) pp. ofae223. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7689B1E13106]
 
What do We Know about Cryptic Aspergillosis?
Geremia N., Giovagnorio F., Colpani A., De Vito A., Caruana G., Meloni M.C., Madeddu G., Panese S., Parisi S.G., 2024/04/28. Microorganisms, 12 (5). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C3F5BE7EABC]
Inter-phylum circulation of a beta-lactamase-encoding gene: a rare but observable event.
Gschwind R., Petitjean M., Fournier C., Lao J., Clermont O., Nordmann P., Mellmann A., Denamur E., Poirel L., Ruppé E., 2024/04/03. Antimicrobial agents and chemotherapy, 68 (4) pp. e0145923. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E89213DEE11]
 
Chlamydia pneumoniae Upsurge at Tertiary Hospital, Lausanne, Switzerland.
Tagini F., Opota O., Greub G., 2024/04. Emerging infectious diseases, 30 (4) pp. 810-812. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F55B387540AA]
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M., Giacobbe D.R., Agvald-Ohman C., Akova M., Alastruey-Izquierdo A., Arikan-Akdagli S., Azoulay E., Blot S., Cornely O.A., Cuenca-Estrella M. et al., 2024/04. Intensive care medicine, 50 (4) pp. 502-515. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F8D4AD6C304]
 
PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?
Lamoth F., Kontoyiannis D.P., 2024/04. Expert review of molecular diagnostics, 24 (4) pp. 273-282. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4A39ECDF6EF]
 
Disease Burden and Inpatient Management of Children with Acute Respiratory Viral Infections during the Pre-COVID Era in Germany: A Cost-of-Illness Study.
Alchikh M., Conrad TOF, Obermeier P.E., Ma X., Schweiger B., Opota O., Rath B.A., 2024/03/26. Viruses, 16 (4). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C35C07FF3D1C]
Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit.
Stavropoulou E., Huguenin A., Caruana G., Opota O., Perrottet N., Blanc D.S., Grandbastien B., Senn L., Bochud P.Y., Lamoth F., 2024/03/26. Swiss medical weekly, 154 p. 3730. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4091A856E587]
Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform.
Sturm A., Jóźwiak G., Verge M.P., Munch L., Cathomen G., Vocat A., Luraschi-Eggemann A., Orlando C., Fromm K., Delarze E. et al., 2024/03/18. Nature communications, 15 (1) p. 2037. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ABB57C7C3258]
Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.
Filippidis P., Hovius L., Tissot F., Orasch C., Flückiger U., Siegemund M., Pagani J.L., Eggimann P., Marchetti O., Lamoth F. et al., 2024/03/11. Journal of critical care, 82 p. 154772. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB2800A65195]
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
Kusejko K., Neofytos D., van Delden C., Hirsch H.H., Meylan P., Boggian K., Hirzel C., Garzoni C., Sidler D., Schnyder A. et al., 2024/03. Open forum infectious diseases, 11 (3) pp. ofae055. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0BE70CAAD5F0]
Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.
Kotliar D., Raju S., Tabrizi S., Odia I., Goba A., Momoh M., Sandi J.D., Nair P., Phelan E., Tariyal R. et al., 2024/03. Nature microbiology, 9 (3) pp. 751-762. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4A26AEC12698]
 
Lung and sinus fungal infection imaging in immunocompromised patients.
Lamoth F., Prakash K., Beigelman-Aubry C., Baddley J.W., 2024/03. Clinical microbiology and infection, 30 (3) pp. 296-305. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4DC53B97B3DF]
Aberrant Bodies: An Alternative Metabolic Homeostasis Allowing Survivability?
Kozusnik T., Adams S.E., Greub G., 2024/02/29. Microorganisms, 12 (3). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2EE85EDC846C]
The Chlamydia-related Waddlia chondrophila encodes functional type II toxin-antitoxin systems.
Ardissone S., Greub G., 2024/02/21. Applied and environmental microbiology, 90 (2) pp. e0068123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7D7FE3E9C165]
 
Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case-control study.
Alberto C., Lambeng N., Deffert C., Breville G., Gayet-Ageron A., Lalive P., Calmy A., Coste A., Papadimitriou-Olivgeris M., Braun D. et al., 2024/02/19. Sexually transmitted infections, 100 (2) pp. 63-69. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F0E982EA4EF]
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA450EA2BB8A]
Upc2-mediated mechanisms of azole resistance in Candida auris.
Li J., Aubry L., Brandalise D., Coste A.T., Sanglard D., Lamoth F., 2024/02/06. Microbiology spectrum, 12 (2) pp. e0352623. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D81064ADA623]
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Meyer Sauteur P.M., Beeton M.L., European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group, 2024/02. The Lancet. Microbe, 5 (2) pp. e100-e101. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7B836C67FB62]
Proposed Framework for Conducting Clinically Relevant Translational Biomarker Research for the Diagnosis, Prognosis and Management of Sepsis.
Ventura F., Greub G., Liles W.C., Jacob S.T., 2024/01/30. Diagnostics, 14 (3). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0C23ED34646E]
 
Environmental and geographical factors influencing the spread of SARS-CoV-2 over 2 years: a fine-scale spatiotemporal analysis.
De Ridder D., Ladoy A., Choi Y., Jacot D., Vuilleumier S., Guessous I., Joost S., Greub G., 2024. Frontiers in public health, 12 p. 1298177. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C99A4FC06539]
Impact of mutations in the mtrR, rpdlVD and rrl genes on azithromycin resistance in Neisseria gonorrhoeae.
Mauffrey F., Poncet F., Jacot D., Greub G., Nordmann P., Blanc D.S., 2024. PloS one, 19 (7) pp. e0306695. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_43F212DBA9D3]
2023
Antigenic Architecture of the H7N2 Influenza Virus Hemagglutinin Belonging to the North American Lineage.
Lyashko A.V., Timofeeva T.A., Rudneva I.A., Lomakina N.F., Treshchalina A.A., Gambaryan A.S., Sorokin E.V., Tsareva T.R., Adams S.E., Prilipov A.G. et al., 2023/12/22. International journal of molecular sciences, 25 (1) p. 212. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D3930DDBAE13]
 
From microbiome composition to functional engineering, one step at a time.
Burz S.D., Causevic S., Dal Co A., Dmitrijeva M., Engel P., Garrido-Sanz D., Greub G., Hapfelmeier S., Hardt W-D, Hatzimanikatis V. et al., 2023/12/20. Microbiology and molecular biology reviews, 87 (4) pp. e0006323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_422DE1C48246]
 
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
Huttner A., Agnandji S.T., Engler O., Hooper J.W., Kwilas S., Ricks K., Clements T.L., Jonsdottir H.R., Nakka S.S., Rothenberger S. et al., 2023/12. Clinical microbiology and infection, 29 (12) pp. 1587-1594. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28B2927C0A6D]
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting.
Filippidis P., Senn L., Poncet F., Grandbastien B., Prod'hom G., Greub G., Guery B., Blanc D.S., 2023/12. European journal of clinical microbiology & infectious diseases, 42 (12) pp. 1469-1476. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DBB82905A18B]
 
In vivo reprogramming leads to premature death linked to hepatic and intestinal failure.
Parras A., Vílchez-Acosta A., Desdín-Micó G., Picó S., Mrabti C., Montenegro-Borbolla E., Maroun C.Y., Haghani A., Brooke R., Del Carmen Maza M. et al., 2023/12. Nature aging, 3 (12) pp. 1509-1520. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD54C85E7DB7]
 
Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin.
Findlay J., Sierra R., Raro OHF, Aires-de-Sousa M., Andrey D.O., Nordmann P., 2023/12. Journal of global antimicrobial resistance, 35 pp. 137-142. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_295F629F6EEE]
Publisher Correction: Fungal antigenic variation using mosaicism and reassortment of subtelomeric genes' repertoires.
Meier C.S., Pagni M., Richard S., Mühlethaler K., Almeida JMGCF, Nevez G., Cushion M.T., Calderón E.J., Hauser P.M., 2023/12/01. Nature communications, 14 (1) p. 7928. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_754F4A526A6E]
Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii.
Raro OHF, Bouvier M., Kerbol A., Decousser J.W., Poirel L., Nordmann P., 2023/12. European journal of clinical microbiology & infectious diseases, 42 (12) pp. 1511-1518. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_076EA289DE46]
Effect of Zinc Oxide and Copper Sulfate on Antibiotic Resistance Plasmid Transfer in Escherichia coli.
Raro OHF, Poirel L., Nordmann P., 2023/11/29. Microorganisms, 11 (12) p. 2880. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BCED521EFF68]
Sex and Age Impact CD4+ T Cell Susceptibility to HIV In Vitro through Cell Activation Dynamics.
Brandt L., Angelino P., Martinez R., Cristinelli S., Ciuffi A., 2023/11/23. Cells, 12 (23) p. 2689. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_475AE3709556]
Presence and Persistence of Andes Virus RNA in Human Semen.
Züst R., Ackermann-Gäumann R., Liechti N., Siegrist D., Ryter S., Portmann J., Lenz N., Beuret C., Koller R., Staehelin C. et al., 2023/11/17. Viruses, 15 (11) p. 2266. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_034CE3FBD3D4]
Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland.
Schürch S., Gindro K., Schnee S., Dubuis P.H., Codina J.M., Wilhelm M., Riat A., Lamoth F., Sanglard D., 2023/11/06. Medical mycology, 61 (11) pp. myad110. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_33FFF4F070B5]
Rapid detection of temocillin resistance in Enterobacterales.
Findlay J., Poirel L., Nordmann P., 2023/11/06. The Journal of antimicrobial chemotherapy, 78 (11) pp. 2770-2771. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A639ECD6528]
Fungal antigenic variation using mosaicism and reassortment of subtelomeric genes' repertoires.
Meier C.S., Pagni M., Richard S., Mühlethaler K., Almeida JMGCF, Nevez G., Cushion M.T., Calderón E.J., Hauser P.M., 2023/11/02. Nature communications, 14 (1) p. 7026. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EC236B91675E]
Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe.
Mitjà O., Padovese V., Folch C., Rossoni I., Marks M., Rodríguez I Arias M.A., Telenti A., Ciuffi A., Blondeel K., Mårdh O. et al., 2023/11. The Lancet regional health. Europe, 34 p. 100742. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7666DEB4C659]
Luminescent reporter cells enable the identification of broad-spectrum antivirals against emerging viruses.
Löw K., Möller R., Stegmann C., Becker M., Rehburg L., Obernolte H., Schaudien D., Oestereich L., Braun A., Kunz S. et al., 2023/11. Journal of medical virology, 95 (11) pp. e29211. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9E0FB478BF6A]
 
Rapid detection of imipenem/relebactam susceptibility/resistance in Enterobacterales
Bouvier Maxime, Raro Otávio Hallal Ferreira, Kerbol Auriane, Poirel Laurent, Nordmann Patrice, 2023/11. Clinical Microbiology and Infection, 29 (11) pp. 1453.e1-1453.e5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F24D1BAD2273]
Resist Acineto rapid immunological test for the detection of acquired carbapenemase producers among Acinetobacter spp.
Bouvier M., Kerbol A., Findlay J., Freire S., Poirel L., Nordmann P., 2023/11. Diagnostic microbiology and infectious disease, 107 (3) p. 116043. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC31F12326DB]
 
Securing the future of clinical microbiology and infectious diseases through mentorship
Neidhöfer Claudio, Kherabi Yousra, Van Asten Suzanne, Bulescu Casandra, Kraef Christian, Power Nicholas, Caruana Giorgia, Velikov Petar, 2023/11. Clinical Microbiology and Infection, 29 (11) pp. 1358-1360. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E58E4AA69C48]
 
Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in Enterobacterales.
Viguier C., Bouvier M., Sadek M., Kerbol A., Poirel L., Nordmann P., 2023/10/24. Journal of clinical microbiology, 61 (10) pp. e0058823. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13DB72E15498]
 
Non-Steroidal Estrogens Inhibit Influenza Virus by Interacting with Hemagglutinin and Preventing Viral Fusion.
Franzi E., Mathez G., Dinant S., Deloizy C., Kaiser L., Tapparel C., Le Goffic R., Cagno V., 2023/10/19. International journal of molecular sciences, 24 (20). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_09A468D24391]
An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates.
Aubry R., Buyck J., Prouvensier L., Decousser J-W, Nordmann P., Wicha S.G., Marchand S., Grégoire N., 2023/10/18. Antimicrobial agents and chemotherapy, 67 (10) pp. e0030123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F2F78850D8C]
 
Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Escherichia coli.
Le Terrier C., Nordmann P., Bouvier M., Poirel L., 2023/10/18. Antimicrobial agents and chemotherapy, 67 (10) pp. e0054723. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C94989B9E28D]
Rapid meropenem/vaborbactam NP test for detecting susceptibility/resistance in Enterobacterales.
Nordmann P., Kerbol A., Bouvier M., Sadek M., Poirel L., Raro OHF, 2023/10/03. The Journal of antimicrobial chemotherapy, 78 (10) pp. 2428-2434. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9DFA384D6161]
Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO).
Fischer F.B., Bigler M., Mäusezahl D., Hattendorf J., Egli A., Julian T.R., Rölli F., Gaia V., Wymann M., Fridez F. et al., 2023/10. Infection, 51 (5) pp. 1467-1479. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_60B326644788]
Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosis.
Vocat A., Sturm A., Jóźwiak G., Cathomen G., Świątkowski M., Buga R., Wielgoszewski G., Cichocka D., Greub G., Opota O., 2023/10. Microbes and infection, 25 (7) p. 105151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6922CABC8BD6]
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians.
Casutt A., Lamoth F., Lortholary O., Prior J.O., Tonglet A., Manuel O., Bergeron A., Beigelman-Aubry C., 2023/09/30. European respiratory review, 32 (169). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6BA7EC326862]
Ticks and Chlamydia-Related Bacteria in Swiss Zoological Gardens Compared to in Contiguous and Distant Control Areas.
Vanat V., Aeby S., Greub G., 2023/09/30. Microorganisms, 11 (10) p. 2468. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_82820DB1EEA6]
Spontaneous Aberrant Bodies Formation in Human Pneumocytes Infected with Estrella lausannensis.
Rovero A., Kebbi-Beghdadi C., Greub G., 2023/09/22. Microorganisms, 11 (10) p. 2368. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_34EFA3AE06FC]
Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood.
Jonsdottir H.R., Zysset D., Lenz N., Siegrist D., Ruedin Y., Ryter S., Züst R., Geissmann Y., Ackermann-Gäumann R., Engler O.B. et al., 2023/09/21. Scientific reports, 13 (1) p. 15718. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1943D89C14E6]
IVDR: Analysis of the Social, Economic, and Practical Consequences of the Application of an Ordinance of the In Vitro Diagnostic Ordinance in Switzerland.
Coste A.T., Egli A., Schrenzel J., Nickel B., Zbinden A., Lienhard R., Dumoulin A., Risch M., Greub G., Coordinated Clinical Commission of Microbiology (CCCM), 2023/09/11. Diagnostics, 13 (18). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DA76705655D]
Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer.
Hallal Ferreira Raro O., Poirel L., Tocco M., Nordmann P., 2023/09/05. The Journal of antimicrobial chemotherapy, 78 (9) pp. 2209-2216. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_005D317B554A]
Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern.
Le Terrier C., Nordmann P., Buchs C., Di DYW, Rossolini G.M., Stephan R., Castanheira M., Poirel L., 2023/09/05. The Journal of antimicrobial chemotherapy, 78 (9) pp. 2382-2384. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4ACC7D2F035]
 
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren P.J., Porreca I., Iaconis G., Mok H.P., Mukhopadhyay S., Karakoc E., Cristinelli S., Pomilla C., Bartha I., Thorball C.W. et al., 2023/09. Nature, 621 (7979) pp. E42. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5534E0BE7C51]
Use of gene sequences as type for naming prokaryotes: Recommendations of the international committee on the taxonomy of chlamydiae.
Greub G., Pillonel T., Bavoil P.M., Borel N., Campbell L.A., Dean D., Hefty S., Horn M., Morré S.A., Ouellette S.P. et al., 2023/09. New microbes and new infections, 54 p. 101158. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7184AA4BCCD0]
Small Molecules Targeting Viral RNA.
Mathez G., Cagno V., 2023/08/31. International journal of molecular sciences, 24 (17) p. 13500. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E1C585CD109]
 
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T., Choi Y., Pagani J.L., Kritikos A., Papadimitriou-Olivgeris M., Méan M., Scherz V., Opota O., Greub G., Guery B. et al., 2023/08/18. BMC infectious diseases, 23 (1) p. 537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4AC9A4A0DF4]
 
International Committee on Systematics of Prokaryotes Subcommittee on the taxonomy of Chlamydiae: Minutes of the closed meeting, March 20, Meeting of the Chlamydia Research Society, Omaha, NE, USA
Borel Nicole, Greub Gilbert, 2023/08/16. International Journal of Systematic and Evolutionary Microbiology, 73 (8). Peer-reviewed.
[DOI][WoS][serval:BIB_25235C535556]
 
Oedème palpébral 24 heures après le premier vaccin contre le COVID-19
Dao Mai-Chi Diane, Opota Onya, Blum Sabine, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_03E4EDAE9BE2]
 
Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren P.J., Porreca I., Iaconis G., Mok H.P., Mukhopadhyay S., Karakoc E., Cristinelli S., Pomilla C., Bartha I., Thorball C.W. et al., 2023/08. Nature, 620 (7976) pp. 1025-1030. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1BEC83916D3]
Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?
Albrich W.C., Lamoth F., 2023/08/01. American journal of respiratory and critical care medicine, 208 (3) pp. 230-231. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4D978DCE1AD4]
 
Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa.
Le Terrier C., Nordmann P., Freret C., Seigneur M., Poirel L., 2023/07/18. Antimicrobial agents and chemotherapy, 67 (7) pp. e0033923. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AADBA96B8DD]
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F., Nucci M., Fernandez-Cruz A., Azoulay E., Lanternier F., Bremerich J., Einsele H., Johnson E., Lehrnbecher T., Mercier T. et al., 2023/07/06. Medical mycology, 61 (7). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_898CA72EA941]
The Statistical Analysis of the Varying Brain.
Chén Oliver Y., Thanh Vũ Duy, Greub Gilbert, Cao Hengyi, He Xingru, Muller Yannick, Petrovas Constantinos, Shou Haochang, Nguyen Viet-Dung, Zhi Bangdong et al., 2023/07/02. IEEE Statistical Signal Processing (SSP). Peer-reviewed.
[URN][DOI][WoS][serval:BIB_C6B3B6AA1F8B]
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Haefliger D., Marzolini C., Lamoth F., Pabst T., Buclin T., Livio F., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 2304-2308. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BC838D4B328]
Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection.
Bermúdez-Méndez E., Angelino P., van Keulen L., van de Water S., Rockx B., Pijlman G.P., Ciuffi A., Kortekaas J., Wichgers Schreur P.J., 2023/06/29. Journal of virology, 97 (6) pp. e0041523. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE795E94CEDA]
Novel Approaches in the Management of Mucormycosis
Lamoth Frederic, 2023/06. Current Fungal Infection Reports, 17 (2) pp. 98-107.
[URN][DOI][WoS][Pmid][serval:BIB_FA10AFF52769]
Temperature Affects the Host Range of Rhabdochlamydia porcellionis.
Marquis B., Ardissone S., Greub G., 2023/05/31. Applied and environmental microbiology, 89 (5) pp. e0030923. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_74719FF9DB98]
 
Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales.
Sadek M., Bosch Duran J., Poirel L., Nordmann P., 2023/05/17. Antimicrobial agents and chemotherapy, 67 (5) pp. e0007823. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_10726FB776C5]
Leptospirose, le défi diagnostique d’un cas autochtone [Leptospirosis, the diagnostic challenge of an indigenous case]
Martelli F., Gay Des Combes Gliven P., De Vallière S., Favrat B., Greub G., Kokkinakis I., 2023/05/10. Revue medicale suisse, 19 (826) pp. 916-919. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E6E80C76206E]
Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
de La Harpe R., Thorball C.W., Redin C., Fournier S., Müller O., Strambo D., Michel P., Vollenweider P., Marques-Vidal P., Fellay J. et al., 2023/05/09. European journal of preventive cardiology, 30 (7) pp. 561-571. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A980F8B766B6]
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates.
Le Terrier C., Nordmann P., Sadek M., Poirel L., 2023/05/03. The Journal of antimicrobial chemotherapy, 78 (5) pp. 1191-1194. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EFAE29C261A1]
 
Changes in the fungal nomenclature: Why and how to manage?
Hennequin C., Coste A., Imbert C., 2023/05. Journal de mycologie medicale, 33 (2) p. 101404. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2F90B751F38]
 
Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
Li J., Coste A.T., Liechti M., Bachmann D., Sanglard D., Lamoth F., 2023/05/01. Antimicrobial agents and chemotherapy, 65 (5) pp. e02663-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82EB6D2906CE]
Resistance to ceftazidime-avibactam in a KPC-2-producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25.
Findlay J., Poirel L., Bouvier M., Gaia V., Nordmann P., 2023/05. European journal of clinical microbiology & infectious diseases, 42 (5) pp. 639-644. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E804F0769A7A]
The Swiss Pathogen Surveillance Platform - towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata.
Neves A., Walther D., Martin-Campos T., Barbie V., Bertelli C., Blanc D., Bouchet G., Erard F., Greub G., Hirsch H.H. et al., 2023/05. Microbial genomics, 9 (5). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7F921402DD4E]
Échinococcose alvéolaire : prise en charge en 2023 [2023 update on alveolar echinococcosis]
Gauthiez E., Uldry E., Coste A.T., Prior J., Cavassini M., Munting A., 2023/04/12. Revue medicale suisse, 19 (822) pp. 708-712. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3120FE82293D]
 
NDM-9 resistance to taniborbactam.
Le Terrier C., Gruenig V., Fournier C., Nordmann P., Poirel L., 2023/04. The Lancet. Infectious diseases, 23 (4) pp. 401-402. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56C56905C112]
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections.
Sanya DRA, Onésime D., Vizzarro G., Jacquier N., 2023/03/30. BMC microbiology, 23 (1) p. 86. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FCED6FEB66EB]
 
Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland.
Hallal Ferreira Raro O., Nordmann P., Dominguez Pino M., Findlay J., Poirel L., 2023/03/16. Antimicrobial agents and chemotherapy, 67 (3) pp. e0142422. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1A13E0CC95B]
 
Rectal shedding of monkeypox virus in a patient coinfected with Chlamydia trachomatis and Neisseria gonorrhoeae: a case report.
Desgranges F., Glampedakis E., Christinet V., Encarnação S., Fernandes C., Greub G., Opota O., Cavassini M., 2023/03/06. Journal of medical case reports, 17 (1) p. 94. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F21C7D1F691]
Emergence of OXA-484, an OXA-48-type beta-lactamase, in Switzerland.
Findlay J., Duran J.B., Poirel L., Nordmann P., 2023/03. Journal of global antimicrobial resistance, 32 pp. 131-133. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C48C25B9D1DB]
In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates.
Findlay J., Poirel L., Nordmann P., 2023/03. Journal of global antimicrobial resistance, 32 pp. 66-71. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_20B767F33E6D]
SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works.
Cassari L., Pavan A., Zoia G., Chinellato M., Zeni E., Grinzato A., Rothenberger S., Cendron L., Dettin M., Pasquato A., 2023/03/01. International journal of molecular sciences, 24 (5) p. 4791. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BAA4E8CC98CA]
What Is New in Pulmonary Mucormycosis?
Danion F., Coste A., Le Hyaric C., Melenotte C., Lamoth F., Calandra T., Garcia-Hermoso D., Aimanianda V., Lanternier F., Lortholary O., 2023/02/28. Journal of fungi, 9 (3) p. 307. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC89D4B5FCED]
 
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A., Caruana G., Poissy J., Mamin A., Bachmann D., Pagani J.L., Coste A.T., Lamoth F., 2023/02/22. Journal of clinical microbiology, 61 (2) pp. e0169122. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24963B96DCC0]
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Maertens J., Lodewyck T., Donnelly J.P., Chantepie S., Robin C., Blijlevens N., Turlure P., Selleslag D., Baron F., Aoun M. et al., 2023/02/18. Clinical infectious diseases, 76 (4) pp. 674-682. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E34CCCFF4BB8]
 
Overruling of Procalcitonin-Guided Antibiotics for Lower Respiratory Tract Infections in Primary Care: Ancillary Study of a Randomized Controlled Trial.
Knüsli J., Lhopitallier L., Kronenberg A., Meuwly J.Y., Opota O., Perrenoud M.A., Page M.A., Kain K.C., Mamin A., D'Acremont V. et al., 2023/02/12. Antibiotics, 12 (2) p. 377. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2E38A89B4D4]
An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis.
Reuter J., Otten C., Jacquier N., Lee J., Mengin-Lecreulx D., Löckener I., Kluj R., Mayer C., Corona F., Dannenberg J. et al., 2023/02. PLoS pathogens, 19 (2) pp. e1011047. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E31A9E52AEF0]
 
Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains.
Cuénod A., Aerni M., Bagutti C., Bayraktar B., Boz E.S., Carneiro C.B., Casanova C., Coste A.T., Damborg P., van Dam D.W. et al., 2023/02. Clinical microbiology and infection, 29 (2) pp. 190-199. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0CFEBB3DD03]
 
International Committee on Systematics of Prokaryotes (ICSP) Subcommittee on the taxonomy of Chlamydiae: Minutes of the closed meeting, 25 August 2022, ESCCAR Meeting Lausanne, Switzerland
Borel Nicole, Greub Gilbert, 2023/01/27. dans International Journal of Systematic and Evolutionary Microbiology, Microbiology Society.
[DOI][WoS][serval:BIB_112C0F9D2CBE]
 
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.
Nadeau S.A., Vaughan T.G., Beckmann C., Topolsky I., Chen C., Hodcroft E., Schär T., Nissen I., Santacroce N., Burcklen E. et al., 2023/01/25. Science translational medicine, 15 (680) pp. eabn7979. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD53A1467C94]
Estimation de l’incidence de covid long en 2020 ou 2021 (Periode pre-omicron).
Meylan P., 2023/01/18. Revue medicale suisse, 19 (809-10) pp. 90-91. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_32E30581F43B]
A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia.
Asare P.T., Lee C.H., Hürlimann V., Teo Y., Cuénod A., Akduman N., Gekeler C., Afrizal A., Corthesy M., Kohout C. et al., 2023. Frontiers in microbiology, 14 p. 1104707. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3CB9A6F82FA0]
Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: A prospective comparative clinical trial.
Schwob J.M., Miauton A., Petrovic D., Perdrix J., Senn N., Gouveia A., Jaton K., Opota O., Maillard A., Minghelli G. et al., 2023. PloS one, 18 (2) pp. e0282150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E11C27628AE5]
Associations of genetic and infectious risk factors with coronary heart disease.
Hodel F., Xu Z.M., Thorball C.W., de La Harpe R., Letang-Mathieu P., Brenner N., Butt J., Bender N., Waterboer T., Marques-Vidal P.M. et al., 2023. eLife, 12 pp. e79742. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ACB0182B565D]
 
Beyond Traditional Culture: New Approaches for a Rapid Detection and Identification of Microorganisms and their Antimicrobial Resistance
Jordana-Lluch Elena, Mancini Nicasio, W. A. Rossen John, Opota Onya, 2023., Frontier Media SA.
[URN][DOI][serval:BIB_7A94974A04CB]
 
Corrigendum: A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia.
Asare P.T., Lee C.H., Hürlimann V., Teo Y., Cuénod A., Akduman N., Gekeler C., Afrizal A., Corthesy M., Kohout C. et al., 2023. Frontiers in microbiology, 14 p. 1208177. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D28F1D58D895]
Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician.
Lamoth F., 2023. Infection and drug resistance, 16 pp. 1087-1097. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0FEB39DECCD1]
Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.
Boldi M.O., Denis-Lessard J., Neziri R., Brouillet R., von-Garnier C., Chavez V., Mazza-Stalder J., Jaton K., Greub G., Opota O., 2023. Frontiers in cellular and infection microbiology, 13 p. 1131241. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4A71366B41B]
Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa.
Sadek M., Le Guern R., Kipnis E., Gosset P., Poirel L., Dessein R., Nordmann P., 2023/01. European journal of clinical microbiology & infectious diseases, 42 (1) pp. 61-66. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5982A68F66EF]
 
Proprotein convertases regulate trafficking and maturation of key proteins within the secretory pathway
Cendron Laura, Rothenberger Sylvia, Cassari Leonardo, Dettin Monica, Pasquato Antonella, 2023. pp. 1-54 dans Secretory Proteins, Elsevier.
[DOI][Pmid][serval:BIB_98B1B3E6D97F]
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection.
Jacot D., von Rotz U., Pellaton C., Blondet F., Aebischer O., Perreau M., De Rham M., Pantaleo G., Marchetti O., Greub G., 2023. Microbes and infection, 25 (1-2) p. 105077. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35EA6DCB0511]
 
Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.
Gachoud D., Bertelli C., Rufer N., 2023/01. British journal of haematology, 200 (2) pp. e25-e27. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4E3F68CC193D]
 
Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice
Schrevens Sanne, Torelli Riccardo, Sanguinetti Maurizio, Sanglard Dominque, 2023. pp. 239-247 dans Antifungal Drug Resistance, Springer US.
[DOI][Pmid][serval:BIB_005F9CC2A3CD]
2022
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F., Calandra T., 2022/12/31. European respiratory review, 31 (166) p. 220114. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D58141CCAB19]
Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital.
Munting A., Damas J., Viala B., Prod'hom G., Guery B., Senn L., 2022/12/30. Antimicrobial resistance and infection control, 11 (1) p. 165. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3F2F6AB9DDC0]
 
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases.
Le Terrier C., Nordmann P., Poirel L., 2022/12/23. The Journal of antimicrobial chemotherapy, 78 (1) pp. 101-107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D546ADCE443C]
Anidulafungin Treatment Blocks the Sexual Cycle of Pneumocystis murina and Prevents Growth and Survival without Rescue by an Alternative Mode of Replication.
Cushion M.T., Ashbaugh A., Sayson S.G., Mosley C., Hauser P.M., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0290622. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F2034698EFCC]
 
Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON).
Kritikos A., Caruana G., Lazor-Blanchet C., Currat M., Chiche J.D., Vollenweider P., Bart P.A., Opota O., Greub G., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0392322. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A6FC8A196FD]
 
Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak.
Cameron D.R., Pitton M., Oberhaensli S., Schlegel K., Prod'hom G., Blanc D.S., Jakob S.M., Que Y.A., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0274322. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E52CF25CDD1]
Alpha and Omicron SARS-CoV-2 Adaptation in an Upper Respiratory Tract Model.
Mathez G., Pillonel T., Bertelli C., Cagno V., 2022/12/20. Viruses, 15 (1) p. 13. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CFE384F7B79]
Evaluation of novel immunological rapid test (K.N.I.V.O. Detection K-Set) for rapid detection of carbapenemase producers in multidrug-resistant gram negatives.
Sadek M., Bouvier M., Kerbol A., Poirel L., Nordmann P., 2022/12. Diagnostic microbiology and infectious disease, 104 (4) p. 115761. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C289C1D68C5C]
Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting.
Varricchio C., Mathez G., Pillonel T., Bertelli C., Kaiser L., Tapparel C., Brancale A., Cagno V., 2022/12. Antiviral research, 208 p. 105452. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF55BB6045C7]
 
In vitro synergistic action of TAT-RasGAP<sub>317-326</sub> peptide with antibiotics against Gram-negative pathogens.
Vizzarro G., Jacquier N., 2022/12. Journal of global antimicrobial resistance, 31 pp. 295-303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_481231D0BEE6]
 
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.
Bergeron A., Mikulska M., De Greef J., Bondeelle L., Franquet T., Herrmann J.L., Lange C., Spriet I., Akova M., Donnelly J.P. et al., 2022/12. The Lancet. Infectious diseases, 22 (12) pp. e359-e369. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D27571AAE071]
 
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis.
Giacobbe D.R., Asperges E., Cortegiani A., Grecchi C., Rebuffi C., Zuccaro V., Scudeller L., Bassetti M., FUNDICU investigators, 2022/12. Mycoses, 65 (12) pp. 1073-1111. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29BAF1D8832A]
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
Rothenberger S., Hurdiss D.L., Walser M., Malvezzi F., Mayor J., Ryter S., Moreno H., Liechti N., Bosshart A., Iss C. et al., 2022/12. Nature biotechnology, 40 (12) pp. 1845-1854. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AD493D8193DB]
The «Amish» NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation.
Redin C., Pavlidou D.C., Bhuiyan Z., Porretta A.P., Monney P., Bedoni N., Maurer F., Sekarski N., Atallah I., Émeline D. et al., 2022/12. European journal of medical genetics, 65 (12) p. 104627. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_36267BDE9D6F]
Using in vivo transcriptomics and RNA enrichment to identify genes involved in virulence of Candida glabrata.
Schrevens S., Durandau E., Tran VDT, Sanglard D., 2022/12. Virulence, 13 (1) pp. 1285-1303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_64DDC512E381]
 
Variability of Primary Sjögren's Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus.
Trutschel D., Bost P., Mariette X., Bondet V., Llibre A., Posseme C., Charbit B., Thorball C.W., Jonsson R., Lessard C.J. et al., 2022/12. Arthritis & rheumatology, 74 (12) pp. 1991-2002. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E91D437CA3D3]
 
Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales.
Nordmann P., Bouvier M., Poirel L., Sadek M., 2022/11/28. The Journal of antimicrobial chemotherapy, 77 (12) pp. 3456-3461. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CEE8863BDB0A]
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms.
Bianco G., Gaibani P., Comini S., Boattini M., Banche G., Costa C., Cavallo R., Nordmann P., 2022/11/22. Antibiotics, 11 (12). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4954A14547F]
Investigating nanomotion-based technology (Resistell AST) for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: protocol for a prospective, observational, cross-sectional, single-arm study.
Caruana G., Kritikos A., Vocat A., Luraschi A., Delarze E., Sturm A., Pla Verge M., Jozwiak G., Kushwaha S., Delaloye J. et al., 2022/11/21. BMJ open, 12 (11) pp. e064016. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AD482F96FC1]
 
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Mercier T., Desfontaine V., Cruchon S., Da Silva Pereira Clara J.A., Briki M., Mazza-Stalder J., Kajkus A., Burger R., Suttels V., Buclin T. et al., 2022/11/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1211 p. 123456. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BD27ECE6B02]
 
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents.
Gachoud D., Pillonel T., Tsilimidos G., Battolla D., Dumas D., Opota O., Fontana S., Vollenweider P., Manuel O., Greub G. et al., 2022/11. British journal of haematology, 199 (4) pp. 549-559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_801AF06A907A]
Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.
Findlay J., Perreten V., Poirel L., Nordmann P., 2022/11. European journal of clinical microbiology & infectious diseases, 41 (11) pp. 1355-1360. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65F2E9192F78]
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data.
Bassetti M., Zuccaro V., Asperges E., Scudeller L., Giacobbe D.R., FUNDICU investigators (collaborators), 2022/11. The Journal of infection, 85 (5) pp. 573-607. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_952422A46B1B]
Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase.
Sadek M., Saad A.M., Nordmann P., Poirel L., 2022/10/26. Antibiotics, 11 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A7BED5ECE8DD]
Lignin: A Sustainable Antiviral Coating Material.
Boarino A., Wang H., Olgiati F., Artusio F., Özkan M., Bertella S., Razza N., Cagno V., Luterbacher J.S., Klok H.A. et al., 2022/10/24. ACS sustainable chemistry & engineering, 10 (42) pp. 14001-14010. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3B7ACCB0CA6D]
 
In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae.
Findlay J., Rens C., Poirel L., Nordmann P., 2022/10/18. Antimicrobial agents and chemotherapy, 66 (10) pp. e0091822. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_386EC44F9DD6]
Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
Walser M., Mayor J., Rothenberger S., 2022/10/12. Viruses, 14 (10) p. 2242. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2AE29CC09CEA]
An anti-influenza combined therapy assessed by single cell RNA-sequencing.
Medaglia C., Kolpakov I., Zwygart A.C., Zhu Y., Constant S., Huang S., Cagno V., Dermitzakis E.T., Stellacci F., Xenarios I. et al., 2022/10/10. Communications biology, 5 (1) p. 1075. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3AC2D9872A21]
Cross-reaction of naturally-produced β-lactamases from Citrobacter farmeri and Citrobacter amalonaticus with immunological detection of CTX-M enzymes.
Ortiz de la Rosa J.M., Bouvier M., Poirel L., Greub G., Blanc D., Nordmann P., 2022/10. Diagnostic microbiology and infectious disease, 104 (2) p. 115760. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AC11CB2E861D]
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Laager M., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2022/10. The Journal of hospital infection, 128 pp. 47-53. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CFE763A8A63]
Author Correction: Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin.
Staub E., Marti H., Biondi R., Levi A., Donati M., Leonard C.A., Ley S.D., Pillonel T., Greub G., Seth-Smith HMB et al., 2022/09/28. Scientific reports, 12 (1) p. 16171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9538A452E4A7]
 
Prevalence and Factors Associated with Prosthetic Joint Infections in Patients with Staphylococcus aureus Bacteraemia: A 7-Year Retrospective Study.
Papadimitriou-Olivgeris M., Senn L., Bertelli C., Grandbastien B., Steinmetz S., Boillat-Blanco N., 2022/09/28. Antibiotics, 11 (10) p. 1323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6E9D65B4BFE]
A novel Candida glabrata doxycycline-inducible system for in vitro/in vivo use.
Schrevens S., Sanglard D., 2022/09/24. FEMS yeast research, 22 (1) pp. foac046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_929A453880B7]
The importance of antimicrobial resistance in medical mycology.
Gow NAR, Johnson C., Berman J., Coste A.T., Cuomo C.A., Perlin D.S., Bicanic T., Harrison T.S., Wiederhold N., Bromley M. et al., 2022/09/12. Nature communications, 13 (1) p. 5352. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC8486DC2F86]
In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
Findlay J., Poirel L., Bouvier M., Nordmann P., 2022/09. Journal of global antimicrobial resistance, 30 pp. 445-450. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_380444481D30]
 
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.
Lamoth F., Lewis R.E., Kontoyiannis D.P., 2022/08/31. Clinical infectious diseases, 75 (3) pp. 534-544. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_90F243509573]
Cell Fusion May Be Involved in the Homothallic Mating of Pneumocystis Species.
Hauser P.M., Almeida JMGCF, Richard S., Meier C.S., 2022/08/30. mBio, 13 (4) pp. e0085922. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2F4844EF8A54]
 
High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies.
Tschopp J., Brunel A.S., Spertini O., Croxatto A., Lamoth F., Bochud P.Y., 2022/08/25. Clinical infectious diseases, 75 (2) pp. 330-333. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D7EA460AD1EC]
 
NDM-35-Producing ST167 Escherichia coli Highly Resistant to β-Lactams Including Cefiderocol.
Poirel L., Ortiz de la Rosa J.M., Sakaoglu Z., Kusaksizoglu A., Sadek M., Nordmann P., 2022/08/16. Antimicrobial agents and chemotherapy, 66 (8) pp. e0031122. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29A00F7E3FC4]
An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
Hervouet K., Ferrié M., Ankavay M., Montpellier C., Camuzet C., Alexandre V., Dembélé A., Lecoeur C., Foe A.T., Bouquet P. et al., 2022/08. PLoS pathogens, 18 (8) pp. e1010798. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4C125B10C4D]
Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.
Kampouri E., Filippidis P., Wölfle M., Taveira A., Badinski T., Croxatto A., Galperine T., Grandbastien B., Achermann Y., Guery B., 2022/08. Infectious diseases now, 52 (5) pp. 267-272. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D9587F593507]
Host genomics of SARS-CoV-2 infection.
Redin C., Thorball C.W., Fellay J., 2022/08. European journal of human genetics, 30 (8) pp. 908-914. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_610172074A67]
Modelling the Extremes of Seasonal Viruses and Hospital Congestion: The Example of Flu in a Swiss Hospital
Ranjbar S., Cantoni E., Chavez-Demoulin V., Marra G., Radice R., Jaton K., 2022/08/01. Journal of the Royal Statistical Society Series C: Applied Statistics, 71 (4) pp. 884-905.
[URN][DOI][WoS][serval:BIB_35D2D049BD3E]
 
SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
Jacot D., von Rotz U., Blondet F., Aebischer O., Matthieu P., De Rham M., Pantaleo G., Marchetti O., Greub G., 2022/08. Journal of medical microbiology, 71 (8). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E339D4530BF]
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
Papadimitriou-Olivgeris M., Battistolo J., Poissy J., Coste A., Bochud P.Y., Calandra T., Senn L., Lamoth F., 2022/08. Open forum infectious diseases, 9 (8) pp. ofac383. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16BC39E44CF1]
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66CD4B7631A4]
The Impact of Epitranscriptomics on Antiviral Innate Immunity.
Mersinoglu B., Cristinelli S., Ciuffi A., 2022/07/28. Viruses, 14 (8) p. 1666. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_169EFDDEF7AA]
Covid long chez des individus infectés malgré le vaccin et effet du vaccin sur les symptômes.
Meylan P., 2022/07/06. Revue medicale suisse, 18 (789) pp. 1378-1379. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1B7C5E1941E3]
 
Corrigendum to "A probabilistic approach to evaluate salivary microbiome in forensic science when the defense says: 'It is my twin brother'" [Forensic Sci. Int. Genet. 57, 102638].
Bozza S., Scherz V., Greub G., Falquet L., Taroni F., 2022/07..
[DOI][WoS][Pmid][serval:BIB_48280B21B6F2]
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study.
Filippidis P., Kampouri E., Woelfle M., Badinski T., Croxatto A., Galperine T., Papadimitriou-Olivgeris M., Grandbastien B., Achermann Y., Guery B., 2022/06/30. Journal of clinical medicine, 11 (13) p. 3805. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_694295A9316A]
 
The EnvZ/OmpR Two-Component System Regulates the Antimicrobial Activity of TAT-RasGAP<sub>317-326</sub> and the Collateral Sensitivity to Other Antibacterial Agents.
Georgieva M., Heinonen T., Hargraves S., Pillonel T., Widmann C., Jacquier N., 2022/06/29. Microbiology spectrum, 10 (3) pp. e0200921. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C087F8C3B286]
Utility of Polymerase Chain Reaction in Nasopharyngeal Swabs for Identifying Respiratory Bacteria Causing Community-Acquired Pneumonia.
Demars Y., Brahier T., Rotzinger D.C., Brouillet R., Jaton K., Opota O., Boillat-Blanco N., 2022/06/29. Microbiology spectrum, 10 (3) pp. e0037922. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_28C85C8A071E]
 
Performance Evaluation of the Quantamatrix QMAC-dRAST System for Rapid Antibiotic Susceptibility Testing Directly from Blood Cultures.
Rosselin M., Prod'hom G., Greub G., Croxatto A., 2022/06/14. Microorganisms, 10 (6) p. 1212. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ADE99A36A933]
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Born T., Aruanno M., Kampouri E., Mombelli M., Monney P., Tozzi P., Lamoth F., 2022/06. Mycopathologia, 187 (2-3) pp. 249-258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B27A401AB555]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University